Tripos Announces its Latest Release of its Software for Drug Discovery
This latest release further extends the Tripos commitment to providing innovative, integrated software that addresses cutting-edge concerns in drug discovery such as virtual screening, chemical informatics, pharmacophore determination, and ADME. Premiering for the first time in this release are CombiFlexX?, a virtual screening program designed to identify compounds in combinatorial libraries most likely to be effective as new drugs, and HiVol?, a new cheminformatics tool for interactively analyzing and exploring large volumes of high throughput screening and synthesis data. DISCOtech? is an innovative new product that simplifies pharmacophore elucidation and the search for lead compounds, and VolSurf? is a well-respected program of proven utility in the pharmaceutical industry that predicts the ADME properties of potential new drugs.
By supporting a variety of computational platforms, the SYBYL®6.8/UNITY®4.3 release reflects Tripos Discovery Software dedication to accommodating the diverse and ever-changing informatics needs of scientists. While SYBYL, UNITY and all associated applications continue to be supported on SGI hardware, the new release extends beyond this widely recognized platform to include powerful new HP workstations and servers. In addition, FlexX? and CScore? -- part of Tripos' suite of virtual screening tools -- have now been ported to Linux®, making it possible to launch screening experiments from an SGI or HP workstation and distribute the calculations over a high-capacity network of Intel® compatible servers.
Most read news
Organizations
Other news from the department research and development
These products might interest you
Limsophy by AAC Infotray
Optimise your laboratory processes with Limsophy LIMS
Seamless integration and process optimisation in laboratory data management
ERP-Software GUS-OS Suite by GUS
Holistic ERP solution for companies in the process industry
Integrate all departments for seamless collaboration
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.